Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €38.01 EUR
Change Today -1.66 / -4.19%
Volume 26.0
8FM On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 3:55 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert W. Hesslein J.D., Esq.

Senior Vice President and General Counsel, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

61--

Background*

Mr. Robert W. Hesslein, J.D. has been a Senior Vice President and General Counsel of Foundation Medicine, Inc. since May 29, 2012. Mr. Hesslein was previously a Senior Vice President and Deputy General Counsel at Genzyme Corporation, or Genzyme, a biotechnology company based in Cambridge, Massachusetts, which is a wholly-owned subsidiary of Sanofi from 1996 to 2012. Before Genzyme, from 1990 to 1996, Mr. Hesslein was a Second Vice President and Counsel at The New England, ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Yale University
JD
Cornell University School of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8FM:GR €38.01 EUR -1.66

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$433.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kimberly J. Popovits Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$660.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$425.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.